-+ 0.00%
-+ 0.00%
-+ 0.00%

Galmed regains Nasdaq compliance with $1 minimum bid price rule

PUBT·09/08/2026 10:09:20
Listen to the news
Galmed regains Nasdaq compliance with $1 minimum bid price rule
  • Nasdaq notified Galmed on Sept. 3, 2026 that it regained compliance with the $1 minimum bid-price listing rule.
  • Ordinary shares will remain listed on Nasdaq; the listing deficiency matter is closed.
  • Compliance was restored with at least 10 consecutive trading days at $1 or above, from Aug. 20 to Sept. 2, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041656), on September 08, 2026, and is solely responsible for the information contained therein.